15.5-day G7 integrated continuous glucose monitor in adults with diabetes shows positive results

In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day Dexcom G7 integrated continuous glucose monitor (CGM) in adults with diabetes.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup